In patients with ⩾1 baseline Gd+ lesion, CGMV loss reduction did not reach statistical significance at any time point.
← all excerpts
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS.
1
—
—
In patients with ⩾1 baseline Gd+ lesion, CGMV loss reduction did not reach statistical significance at any time point.